BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 226556)

  • 1. A variant of S49 mouse lymphoma cells with enhanced secretion of cyclic AMP.
    Steinberg RA; Steinberg MG; van Daalen Wetters T
    J Cell Physiol; 1979 Sep; 100(3):579-88. PubMed ID: 226556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Honeysett JM; Insel PA
    J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
    Russell JL; Steinberg RA
    J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of lymphoma cell death induced by cyclic AMP.
    Coffino P; Bourne HR; Tomkins GM
    Am J Pathol; 1975 Oct; 81(1):199-204. PubMed ID: 170834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
    O'Donnell JK; Sweet RW; Stadel JM
    Mol Pharmacol; 1991 Jun; 39(6):702-10. PubMed ID: 1646945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
    Martin TF; Ronning SA
    J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic genetic analysis of cyclic AMP action: characterization of unresponsive mutants.
    Bourne HR; Coffino P; Tomkins GM
    J Cell Physiol; 1975 Jun; 85(3):611-20. PubMed ID: 167037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of mutant and wild type protein kinase in lymphoma cells resistant to dibutyryl cyclic AMP.
    Lemaire I; Coffino P
    J Cell Physiol; 1977 Sep; 92(3):437-45. PubMed ID: 198416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP metabolism in an S49 mouse lymphoma variant with diminished phosphodiesterase activity.
    Butcher RW; Barber R; Goka TJ
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):275-90. PubMed ID: 3025277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
    Thomas JM; Hoffman BB
    Mol Pharmacol; 1989 Jan; 35(1):116-24. PubMed ID: 2563303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of protein kinase and adenylate cyclase-deficient variants of a macrophage-like cell line.
    Rosen N; Piscitello J; Schneck J; Muschel RJ; Bloom BR; Rosen OM
    J Cell Physiol; 1979 Jan; 98(1):125-36. PubMed ID: 216704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of S49 lymphoma cell growth by cyclic adenosine 3':5'-monophosphate.
    Coffino P; Gray JW
    Cancer Res; 1978 Nov; 38(11 Pt 2):4285-8. PubMed ID: 212191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dibutyryl cyclic AMP resistant MDCK cells in serum free medium have reduced cyclic AMP dependent protein kinase activity and a diminished effect of PGE1 on differentiated function.
    Devis PE; Grohol SH; Taub M
    J Cell Physiol; 1985 Oct; 125(1):23-35. PubMed ID: 2995425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse lymphoma cells with mutations of cyclic AMP-dependent protein kinase.
    Coffino P
    Natl Cancer Inst Monogr; 1978 May; (48):377-80. PubMed ID: 219362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between cyclic AMP- and phorbol ester-dependent phosphorylation systems in S49 mouse lymphoma cells.
    Kiss Z; Steinberg RA
    J Cell Physiol; 1985 Nov; 125(2):200-6. PubMed ID: 2997237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-site mutations in cyclic AMP-sensitive revertants of a Ka mutant of S49 mouse lymphoma cells reduce the affinity of regulatory subunit of cyclic AMP-dependent protein kinase for catalytic subunit.
    Cauthron RD; Gorman KB; Symcox MM; Steinberg RA
    J Cell Physiol; 1995 Nov; 165(2):376-85. PubMed ID: 7593216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells.
    Wajeman-Chao SA; Lancaster SA; Graf LH; Chambers DA
    J Immunol; 1998 Nov; 161(9):4825-33. PubMed ID: 9794415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants.
    Coffino P; Bourne HR; Tomkins GM
    J Cell Physiol; 1975 Jun; 85(3):603-10. PubMed ID: 167036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
    Niles RM; Loewy B
    J Cell Physiol; 1991 Apr; 147(1):176-81. PubMed ID: 1645360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.